Fifth Third Bancorp
VOR icon

Fifth Third Bancorp’s Vor Biopharma VOR Stock Holding History

Fifth Third Bancorp’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$534 Buy
+28
New +$598 ﹤0.01% 4238

Other funds holding VOR

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Nan Fung Trinity
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.04B AUM 32.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Johnson & Johnson
Johnson & Johnson New Brunswick, New Jersey $762M AUM 69.66% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

Fifth Third Bancorp's VOR Position: Q3 2026 in Review

Fifth Third Bancorp opened a new position in Vor Biopharma (VOR) in Q3 2026: 28 shares worth $534. The stake represents ﹤0.01% of the portfolio and ranks #4238 among its holdings.

47 funds tracked by Wall St. Rank hold VOR as of Q3 2026.

  • Fifth Third Bancorp held 28 shares of Vor Biopharma worth $534 as of Q3 2026.
  • Vor Biopharma was a new Fifth Third Bancorp position in Q3 2026.
  • Vor Biopharma made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q3 2026, its #4238 holding.
  • 47 funds tracked by Wall St. Rank held Vor Biopharma as of Q3 2026.

Based on Fifth Third Bancorp's 13F filing for Q3 2026, filed 5 Nov 2026.